REFERENCES
1. Cheng JC, Wu JK, Huang CM, et al. Radiation-induced liver disease after radiotherapy for hepatocellular carcinoma: clinical manifestation and dosimetric description. Radiother Oncol 2002;63:41-5.
2. Hsin IF, Hsu CY, Huang HC, et al. Liver failure after transarterial chemoembolization for patients with hepatocellular carcinoma and ascites: incidence, risk factors, and prognostic prediction. J Clin Gastroenterol 2011;45:556-62.
3. Liang SX, Zhu XD, Xu ZY, et al. Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance. Int J Radiat Oncol Biol Phys 2006;65:426-34.
4. Salem R, Lewandowski RJ, Mulcahy MF, et al. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology 2010;138:52-64.
5. Teh SH, Nagorney DM, Stevens SR, et al. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology 2007;132:1261-9.
6. Higgins G, Anderson R. Experimental pathology of liver: restoration of liver in white rat following partial surgical removal. Arch Path 1931:202. Avaliable from: https://www.scienceopen.com/document?vid=57858414-5eff-4c8d-a028-ccb3fc1c44a6.[Last accessed on 9 Sep 2024].
7. Bucher NLR, Scott JF, Aub JC. Regeneration of the liver in parabiotic rats. Cancer Res 1951;11:457-65.
8. Wenneker AS, Sussman N. Regeneration of liver tissue following partial hepatectomy in parabiotic rats. Proc Soc Exp Biol Med 1951;76:683-6.
9. Moolten FL, Bucher NL. Regeneration of rat liver: transfer of humoral agent by cross circulation. Science 1967;158:272-4.
13. Andersen KJ, Knudsen AR, Kannerup AS, et al. The natural history of liver regeneration in rats: description of an animal model for liver regeneration studies. Int J Surg 2013;11:903-8.
14. Hadjittofi C, Feretis M, Martin J, Harper S, Huguet E. Liver regeneration biology: Implications for liver tumour therapies. World J Clin Oncol 2021;12:1101-56.
15. Lasley FD, Mannina EM, Johnson CS, et al. Treatment variables related to liver toxicity in patients with hepatocellular carcinoma, child-pugh class a and b enrolled in a phase 1-2 trial of stereotactic body radiation therapy. Pract Radiat Oncol 2015;5:e443-9.
16. Mizumoto M, Okumura T, Hashimoto T, et al. Evaluation of liver function after proton beam therapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2012;82:e529-35.
17. Bennink RJ, Dinant S, Erdogan D, et al. Preoperative assessment of postoperative remnant liver function using hepatobiliary scintigraphy. Nucl Med 2004;45:965-71. Avaliable from: https://jnm.snmjournals.org/content/45/6/965.short.[Last accessed on 9 Sep 2024].
18. Su TS, Li LQ, Liang SX, et al. A prospective study of liver regeneration after radiotherapy based on a new (Su’s) target area delineaton. Front Oncol 2021;11:680303.
19. Bowen SR, Saini J, Chapman TR, et al. Differential hepatic avoidance radiation therapy: proof of concept in hepatocellular carcinoma patients. Radiother Oncol 2015;115:203-10.
20. Bowen SR, Chapman TR, Borgman J, et al. Measuring total liver function on sulfur colloid SPECT/CT for improved risk stratification and outcome prediction of hepatocellular carcinoma patients. EJNMMI Res 2016;6:57.
21. Hoefs JC, Wang F, Kanel G. Functional measurement of nonfibrotic hepatic mass in cirrhotic patients. Am J Gastroenterol 1997;92:2054-8.
22. Zuckerman E, Slobodin G, Sabo E, Yeshurun D, Naschitz JE, Groshar D. Quantitative liver-spleen scan using single photon emission computerized tomography (SPECT) for assessment of hepatic function in cirrhotic patients. J Hepatol 2003;39:326-32.
23. Everson GT, Shiffman ML, Hoefs JC, et al. HALT-C trial group. quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology 2012;55:1019-29.
24. Groshar D, Slobodin G, Zuckerman E. Quantitation of liver and spleen uptake of 99mTc-phytate colloid using SPECT: detection of liver cirrhosis. J Nucl Med 2002;43:312-17.
25. Price RG, Apisarnthanarax S, Schaub SK, et al. Regional radiation dose-response modeling of functional liver in hepatocellular carcinoma patients with longitudinal sulfur colloid SPECT/CT: a proof of concept. Int J Radiat Oncol Biol Phys 2018;102:1349-56.
26. Schaub SK, Apisarnthanarax S, Price RG, et al. Functional liver imaging and dosimetry to predict hepatotoxicity risk in cirrhotic patients with primary liver cancer. Int J Radiat Oncol Biol Phys 2018;102:1339-48.
27. R Core Team. R: a language and environment for statistical computing. Avaliable from: https://www.R-project.org/.[Last accessed on 9 Sep 2024].
28. Rim CH, Park S, Woo JY, Seong J. Compensatory hypertrophy of the liver after external beam radiotherapy for primary liver cancer. Strahlenther Onkol 2018;194:1017-29.
29. Adachi T, Yoshida Y, Shibuya K, et al. Partial liver irradiation in rats induces the hypertrophy of nonirradiated liver lobes through hepatocyte proliferation†. J Radiat Res 2023;64:693-701.
30. de Graaf W, van Lienden KP, Dinant S, et al. Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection. J Gastrointest Surg 2010;14:369-78.
31. Gong WF, Zhong JH, Lu Z, et al. Evaluation of liver regeneration and post-hepatectomy liver failure after hemihepatectomy in patients with hepatocellular carcinoma. Biosci Rep 2019;39:BSR20190088.
32. Richman RA, Claus TH, Pilkis SJ, Friedman DL. Hormonal stimulation of DNA synthesis in primary cultures of adult rat hepatocytes. Proc Natl Acad Sci 1976;73:3589-93.
33. Liu L, Yannam GR, Nishikawa T, et al. The microenvironment in hepatocyte regeneration and function in rats with advanced cirrhosis. Hepatology 2012;55:1529-39.
34. Chuong MD, Kaiser A, Khan F, et al. Consensus report from the miami liver proton therapy conference. Front Oncol 2019;9:457.
